Remdesivir- CAS 1809249-37-3

CAS No.: 1809249-37-3

Inquire Remdesivir (cas: 1809249-37-3 ) online by filling out the inquiry form, we will get back to you within 24 hours!

Remdesivir,1809249-37-3
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I009001
Synonyms:

Remdesivir; GS-5734; GS 5734; GS5734.;2-ethylbutyl ((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[1,2-b]pyridazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate

Molecular Formula:

C27H35N6O8P

Molecular Weight:602.585
Description:Remdesivir(CAS 1809249-37-3), also known as GS-5734, is an antiviral drug, a novel nucleotide analog prodrug. It was developed by Gilead Sciences as a treatment for filovirus infections such as Ebola virus disease and Marburg virus, though it has subsequently also been found to show reasonable antiviral activity against more distantly related viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, and MERS-coronavirus. GS-5734 was rapidly pushed through clinical trials due to the 2013–2016 West African Ebola virus epidemic crisis, eventually being used in at least one human patient despite its early development stage at the time.
Price:185
Inventory Status:In stock!

We would like to match the lowest price on market if possible.

Remdesivir(CAS 1809249-37-3), also known as GS-5734, is an antiviral drug, a novel nucleotide analog prodrug. It was developed by Gilead Sciences as a treatment for filovirus infections such as Ebola virus disease and Marburg virus, though it has subsequently also been found to show reasonable antiviral activity against more distantly related viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, and MERS-coronavirus. GS-5734 was rapidly pushed through clinical trials due to the 2013–2016 West African Ebola virus epidemic crisis, eventually being used in at least one human patient despite its early development stage at the time. Preliminary results have been promising, and further clinical trials are planned. 



Based on success against other coronavirus infections, Gilead provided remdesivir to physicians who treated an American patient in Snohomish County, Washington in 2020, infected with SARS-CoV-2 and is providing the compound to China to conduct a pair of trials in infected individuals with and without severe symptoms.

Chem Calculators

© 2017-2022 MuseChem - A division of ArrakisTek Inc. All Rights Reserved.